Clinical trial
The Prevalence and Significance of Gastro-oesophageal Reflux in Cystic Fibrosis…
NCT00164021 · Bayside Health, Other · Unknown status
Key facts
| NCT number | NCT00164021 |
|---|---|
| Title | The Prevalence and Significance of Gastro-oesophageal Reflux in Cystic Fibrosis Before and After Lung Transplantation |
| Official title | The Prevalence and Significance of Gastro-oesophageal Reflux in Adults With Cystic Fibrosis Before and After Lung Transplantation, Together With the Effects of Physiotherapy Airway Clearance Techniques on Gastro-oesophageal Function |
| Lead sponsor | Bayside Health, Other |
| Collaborators | The Alfred Monash University |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug, Procedure |
| Interventions | Physiotherapy, exercise, percutaneous gastrostomy feeds, Anti-reflux pharmacotherapy |
| Enrollment | 180 |
| Start date | Feb 1, 2001 |
| Primary completion | Dec 1, 2016 |
| First posted | Sep 14, 2005 |
| Last update posted | Jan 15, 2016 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: